Invitrogen™ Transfection Reagent strain Lipofectamine™

Ref.: BL-RE-088217Manufacturer ref.: STEM00001 0 · 1 mL
€103.00 excl. VAT

Lipofectamine stem transfection reagent is optimized to achieve maximum efficiency with minimal early differentiation in a wide range of stem cells. It can co-administer complexes of DNA, d

Classification
Animal origin-free
Content and storage
Store in a refrigerator (2 to 8°C).
Cell type
Stem cell
Type of sample
Cells
Technical transformation
Lipid-based transformation
Brand
Invitrogen

Lipofectamine stem transfection reagent is optimized to achieve maximum efficiency with minimal early differentiation in a wide range of stem cells. It can co-administer complexes of DNA, d

Lipofectamine stem transfection reagent is optimized to achieve maximum efficiency with minimal early differentiation in a wide range of stem cells. It may co-administer complexes of DNA, d-RNA, and ribonucleoprotein Cas9 (RNP). The Lipofectamine Stem reagent is compatible with a large number of media systems, including without conveyor, which helps to support and simplify the workflow of your stem cell culture. Researchers can achieve up to 80% or more transfection efficiency in pluripotent stem cells (PSC) and neural stem cells (NSC), and up to 45% in mesenchymal stem cells (MSC).

Stem cell transfection without inhibiting cell viability and cell growth can be difficult due to the sensitivity of these cells. Lipofectamine Stem is a low toxicity reagent, requiring small amounts of nucleic acid, allowing your stem cells to stay healthy and continue to proliferate without causing differentiation. The Lipofectamine Stem reagent is:

Higher performance: up to 3 times more effective on CSPi, hESCs, NSC and MSC than on other reagents

Polyvalent: a reagent for the DNA, the RNA, the Cas9 protein, and co-transfection

Non-aggressive for cells: maintains cell proliferation without causing differentiation

Flexible: Transfects adhesion or suspension cells: an alternative to electroporation

Achieved high-efficiency genetic editing in stem cells

Genetic assembly applications generally require the ability to co-administer the DNA, the RNA and/or protein in cells. The Lipofectamine Stem Transfection Reagent is designed to co-administer CRISPR/Cas9 complexes in human stem cells for high-efficiency genetic assembly. This unique reagent can be used for transfecting large, all-in-one plasmids of the DNA, such as CRISPR/Cas9 vectors, and providing a range of d-RNA, such as large mRNA Cas9 with tracr/ARNcr complexes or a simple guide RNA (sg), and proteins such as Cas9 protein associated with tracr/ARNcr complex or l-ARNsg.

An alternative of low toxicity to electroporation

Transfection of stem cells by electroporation methods can be difficult and tedious. Electroporation protocols recommend a single cell suspension culture to ensure maximum efficacy and minimal toxicity. Thanks to the reverse transfection protocol, the Lipofectamine Stem transfection reagent proves to be an effective and less toxic alternative to electroporation for stem cells. It requires small amounts of nucleic acid to achieve maximum transfection efficiency by electroporation, while supporting continuous proliferation without inducement of differentiation.

Samples

Type of sample: Cells.

Conservation

Store in a refrigerator (2 to 8°C).

Lipofectamine™ series

It is part of the Lipofectamine™ range.

Packaging

Packaging: 0.1 mL.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15783605
Specifications
ClassificationAnimal origin-free
Cell typeStem cell
Type of sampleCells
Technical transformationLipid-based transformation
For use with (application)Transfection
Product rangeLipofectamine™
Product typeTransfection reagent
Quantity0.1 mL
Compatible with serumNo
Storage and shipping
Content and storageStore in a refrigerator (2 to 8°C).
Shipping conditionsAmbient temperature

Origin and customs

Manufacturer ref.STEM00001
Country of originLituanie
HS customs code3822 19 00 00
A question or a specific configuration?
Contact us for a quote.